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2. ABSTRACT 
 
Cardiac diseases remain the major cause of morbidity and mortality worldwide. This is the 
ground for an increasing number of studies on the characterization of the heart’s response to 
injury and on the development of new therapies to functionally restore the damaged 
myocardium. Recently, several reports show that the mammalian heart, when injured in a short-
period after birth, displays the capacity to regenerate, whereas, if injured after post-natal day 
(P)7, it triggers the formation of a non-functional fibrotic scar. However, the signals that 
determine the development of a reparative (adult) or regenerative response (neonate) are 
largely unknown. The premise of our Team is that the transient regenerative capacity of the 
heart is related to specific organ changes during this ontogenic period. The herein work focuses 
on the dynamics of cardiac fibroblasts and that of the extracellular matrix (ECM) during 
ontogeny and following injury in the neonate. We demonstrate that fibroblasts, here defined as 
the CD31-CD45-Ter119-CD90+ population, colonize the heart following birth and also that the 
cell-surface signature of this compartment changes throughout post-natal life. Our results 
demonstrate that the neonatal heart response to apex resection involves the recruitment of 
inflammatory cells, fibroblast activation, ECM production and neo-vascularization. High Content 
Analysis (HCA) revealed that the removed tissue was, at least in part, re-established by the 
proliferation of resident cardiomyocytes. Moreover, despite formation of scarring tissue (inner 
core of the injured area) and incomplete histological restoration, resected hearts were 
functionally competent at 21d post-lesion. 
Overall this work describes the microenvironmental alterations, with particular emphasis on 
fibroblasts and ECM, triggered following neonatal apex resection and that culminate on partial 
restoration of the organ. 
Keywords: Cardiac Injury, Cardiac Fibroblasts, Extracellular Matrix 
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3. SUMÁRIO 
 
As doenças cardiovasculares são a principal causa de morte nos países de alto e médio 
rendimento. O transplante cardíaco é o único tratamento eficiente a longo prazo, no entanto, 
este é limitado pela baixa disponibilidade de dadores e a necessidade de imunossupressão. Após 
enfarte do miocárdio, a isquemia resulta em elevada morte celular por falta de oxigénio e 
nutrientes. Uma vez que o coração adulto é incapaz de restabelecer os cardiomiócitos perdidos, 
que são a força contráctil do coração, a função sistólica fica diminuída e desenvolve-se tecido 
cicatricial, como resultado de um processo reparativo, na região afectada pela isquemia. 
Consoante a extensão de tecido afectado pelo enfarte este pode ser fatal ou conduzir a uma 
perda progressiva de função.  
Contudo, no início do século XXI, vários foram os estudos que demonstraram que os 
cardiomiócitos proliferam na vida pós-natal, ainda que a uma taxa insuficiente para garantir a 
plena reconstituição do miocárdio após lesão. Esta evidência conduziu a comunidade 
cardiovascular a investigar sinais que possam levar ao melhoramento da resposta do coração ao 
enfarte, nomeadamente estimulando a proliferação de cardiomiócitos. Nesse sentido vários 
modelos animais foram estudados e constatou-se que o peixe-zebra (Danio rerio), o axolote 
(Amblystoma mexicanum) e o tritão (Notophthalmus viridescens) são capazes de recuperar 
histo-funcionalmente de lesões cardíacas induzidas experimentalmente, como é exemplo a 
remoção do ápice cardíaco. Embora estes estudos constituam a primeira evidência de que o 
coração tem potencial regenerativo, a longa distância filogenética entre estes animais e os 
mamíferos, questiona o potencial translacional destes estudos. 
Surpreendentemente, em 2011, Porrello et al. demonstraram que o murganho (Mus musculus) 
detém uma capacidade de regeneração cardíaca transiente, já que esta parece cessar após a 
primeira semana de vida. Após remoção do ápice em animais no primeiro dia de vida os autores 
reportam que o coração é restaurado com fidelidade a nível histo funcional. Contudo, quando a 
mesma lesão é praticada em animais após a primeira semana de vida verificava-se a formação 
de uma cicatriz fibrótica não funcional, semelhante à formada no órgão adulto após enfarte do 
miocárdio. Este estudo revolucionou a área cardiovascular uma vez que se considera que este é 
um modelo útil na identificação de factores importantes para melhorar o processo de reparação 
do coração adulto humano. 
Durante a realização deste trabalho, todavia, Andersen et al. (2014) refutaram a existência de 
regeneração cardíaca em murganho. Os autores verificaram que após remoção do ápice 
cardíaco há activação de uma resposta inflamatória exuberante, formação de uma cicatriz 
fibrótica e que os corações eram sistematicamente mais pequenos e apresentavam menor 
proliferação e vascularização que os respectivos controlos cirúrgicos. Estes resultados 
instalaram na comunidade cardiovascular uma atmosfera de incerteza quanto à 
reprodutibilidade do modelo de lesão neonatal e à capacidade regenerativa dos murganhos 
neonatais.  
O coração é composto por vários tipos celulares, nos quais se incluem os cardiomiócitos, 
elementos vasculares (células do músculo liso e endoteliais) e fibroblastos cardíacos. Atendendo 
à sua elevada frequência no estroma cardíaco, o papel dos fibroblastos cardíacos foi 
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rigorosamente avaliado durante o normal funcionamento do coração e em resposta ao enfarte 
do miocárdio. Apesar da ausência de marcadores fidedignos deste tipo celular, uma vez que 
ainda não foi descrita uma assinatura molecular própria, sabe-se que estas células são essenciais 
para a preservação das propriedades físico-químicas do coração, sendo mesmo as principais 
responsáveis pela produção e secreção da matriz extracelular (ECM) cardíaca. Os fibroblastos 
cardíacos são também produtores de metaloproteinases (MMPs) que degradam a ECM e, como 
tal, este tipo celular é responsável por modelar a composição da matriz, o que por sua vez 
condiciona o comportamento das células aí residentes. Após enfarte do miocárdio, os 
fibroblastos cardíacos migram para o local da lesão, proliferam e diferenciam em 
miofibroblastos, os quais expressam ativamente marcadores de músculo liso e depositam 
colagénio tipo I e III, na região da lesão, gerando uma cicatriz fibrótica não funcional. 
Embora se conheça o papel dos fibroblastos cardíacos na lesão do coração adulto, o seu papel 
na lesão neonatal é totalmente desconhecido. A premissa da equipa Stem Cell 
Microenvironments is Repair/Regeneration do INEB é de que o carácter transiente da 
regeneração cardíaca resulta de alterações no coração quer ao nível da ECM quer ao nível celular 
durante a ontogenia do órgão. 
Neste trabalho, definimos como objectivos a avaliação da dinâmica da população de fibroblastos 
cardíacos e da produção de ECM ao longo do desenvolvimento e maturação do coração, bem 
como durante a resposta à remoção do ápice cardíaco. Usando esta estratégia pretendemos 
investigar se são apresentados/emitidos sinais pela ECM ou pelos fibroblastos cardíacos, que 
promovam a proliferação ou maturação de cardiomiócitos. Através do estabelecimento do 
modelo de ressecção do ápice cardíaco e caracterização histo-funcional do mesmo procuramos 
providenciar dados empíricos que permitam clarificar se ocorre efectivamente activação de 
processos regenerativos em resposta à lesão, nomeadamente processos de proliferação de 
cardiomiócitos.  
Contrariamente ao que foi descrito no trabalho pioneiro de Porrello, nas nossas condições, não 
foi observada a recuperação completa do ápice cardíaco até 60 dias após-cirurgia. Ao invés, 
detectou-se deposição de uma cicatriz fibrótica composta por colagénio, na zona central de 
lesão, ainda que sem impacto detectado na função cardíaca. 
As variações da componente celular e extracelular durante a lesão foram avaliadas através da 
co-detecção de marcadores celulares com proteínas da ECM. Imediatamente após a lesão foi 
possível observar uma disrupção dos padrões de expressão da α-actinina sarcomérica e das 
proteínas da lâmina basal colagénio IV e laminina na zona de lesão, padrões estes que foram 
parcialmente restabelecidos aos 21 dias após a lesão. Durante os primeiros 5 dias verificou-se 
uma forte resposta inflamatória, caracterizada por um elevado número de células 
hematopoiéticas. Todavia aos 7 dias após-lesão o número de células hematopoiéticas decresce 
significativamente e acentua-se a presença de fibroblastos e miofibroblastos. A expressão de 
fibronectina e tenascina-C no local de lesão parece inicialmente estar associada ao coágulo 
sanguíneo e às células hematopoiéticas, no entanto a partir dos 7 dias pós-cirúrgicos, a sua 
produção passa a ser assegurada pelos fibroblastos/miofibroblastos. Conseguimos eficazmente 
correlacionar a expressão de fibronectina e tenascina-C com a proliferação/mitose celular, uma 
vez que é nos locais onde estas proteínas abundam que há maior expressão de PH3. A análise 
quantitativa do número de células mitóticas permitiu identificar um maior número de células 
em mitose e mais especificamente de cardiomiócitos, em corações sujeitos a lesão. 
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Uma vez que observámos activação e diferenciação de fibroblastos em miofibroblastos após 
lesão, decidimos estudar o perfil destas células em maior detalhe. Como nunca foi reportada a 
caracterização de fibroblastos no período pós-natal, avaliámos o perfil de expressão dos 
fibroblastos, identificados com base na expressão de CD90, ao longo da ontogenia bem como 
num cenário de lesão. Os fibroblastos cardíacos instalam-se no miocárdio após-nascimento, de 
forma a constituírem cerca de 60% da população estromal do coração adulto. Adicionalmente, 
o perfil da população proliferativa no adulto parece ser na sua maioria composto por 
fibroblastos. Avaliámos a expressão de diferentes marcadores envolvidos na adesão celular e de 
afiliação mesenquimal na população de fibroblastos, o que salientou a heterogeneidade desta 
população e alterações do perfil de expressão dos diferentes marcadores ao longo da ontogenia. 
De salientar é a população Sca-1+, que aumenta de um nível residual a P2 para mais de 70% dos 
fibroblastos cardíacos (CD90+) no coração adulto.  
A população de fibroblastos cardíacos activados pela lesão é constituída maioritariamente por 
células Sca-1+ e CD44+, verificando-se ainda uma redução significativa da expressão de CD29 e 
de CD140a após lesão. No entanto, considerando o compartimento proliferativo, apenas se 
verificou-se um aumento na população Sca-1+. 
Em suma, demonstrou-se que a resposta do neonatal (P2) à lesão envolve a formação de um 
coágulo sanguíneo, recrutamento de células inflamatórias, proliferação de miofibroblastos, 
rearranjo da matriz extracelular e activação da proliferação de cardiomiócitos. A população de 
fibroblastos cardíacos surge como altamente heterogénea apresentando-se diferente 
consoante o período ontogénico e em resposta à lesão. A relevância funcional das alterações 
observadas após lesão e durante a ontogenia requerem investigação futura. 
Palavras-Chave: Regeneração Cardíaca, Fibroblastos Cardíacos, Matriz Extracelular 
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5.1. Epidemiology of Cardiovascular Diseases 
Ischaemic heart diseases are, according to the World Health Organization (WHO), the leading 
cause of death worldwide (Figure 1). Despite contribution of genetic factors for development of 
cardiac pathologies, most risk factors are behaviourally and environmentally linked, such as: age, 
sex, high blood pressure, hypercholesterolemia, smoking, obesity, alcohol consumption (1); and 
therefore cardiomyopathies are more frequent in middle and higher income countries. 
However, the incidence of ischemic heart diseases is also increasing in developing countries 
mainly due to atherosclerosis-related illnesses (2). 
The only long-term effective treatment for heart failure is heart transplant, which is limited by 
the shortage of donors (3), organ rejection/failure and side effects related to 
immunosuppression (4). This scarcity of therapeutic alternatives has propelled the scientific 
community to question the hypothesis that the working myocardium is a post-mitotic tissue and 
to investigate new biological scenarios in which the heart demonstrates regenerative potential. 
For many years, the view of the heart as a post-mitotic organ has been considered the main 
reason for the myocardial inability to histo-functional restoration following myocardial 
infarction (MI), forming, instead, a non-functional fibrotic scar, as a culmination of a reparative 
response. However, by the turn of the century, several studies demonstrated that 
cardiomyocytes renew during post-natal life. This observation first came from injured hearts. 
According to Beltrami and colleagues, hearts that undergone MI exhibit 70 times more 
cardiomyocyte proliferation in the border zone when compared to healthy hearts and 24 times 
more cardiomyocyte proliferation in distant myocardium (5). Taking advantage of Carbon-14 
integration into DNA, during Cold-War nuclear tests, Bergmann et al. estimated that, in non-
manipulated conditions at the age of 25, annual cardiac turnover is around 1% and that this 
percentage is reduced to 0.45% at the age of 75 (6). The revelation that cardiomyocytes, the 
heart’s working force, could renew both in healthy and in injury conditions, was the proof of 
concept that the heart endows an intrinsic potential that can be potentially optimized in an 
injury scenario. In the years that followed, cardiovascular community focused mainly on the 
origin of newly-formed cardiomyocytes. Two contrasting ideas gradually developed: one 
Figure 1 - Percentage of deathsgrouped by cause for global age-sex groups in 2011. Adapted from (1). 
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claiming that cardiomyocytes originate by the differentiation of myocardium-resident cardiac 
progenitor cells (CPCs), a multipotent cell-type, also able to give rise to endothelial and smooth 
muscle cells, which are scarcely interspersed in the myocardium (7, 8). Alternatively, others have 
proposed that the majority of newly formed cardiomyocytes arise from the proliferation of pre-
existing cardiomyocytes by cell cycle re-entry (5, 6, 9). 
CPCs have been recognized by expression of different cell membrane markers, i.e. c-Kit, Sca-1, 
Abcg-2 and PDGFR-α, and several transcription factors (e.g. Isl-1; Nkx2.5; Gata4 and Wt-1) (10). 
Yet, a universal marker of CPCs is still to be identified (11). Recently, it was demonstrated that 
after selective ablation of c-Kit expressing cells, the restoration of the damaged myocardium 
was halted, being resumed after the replacement of the ablated CPCs with the progeny of one 
c-Kit expressing cell (8). This suggested that c-Kit+ cells are necessary and sufficient for 
myocardial repair. In fact, Stem Cell Infusion in Patients with cardiOmyopathy (SCIPIO) clinical 
trial have shown a significant improvement of the left ventricle ejection fraction in infarcted 
patients (12). A different human clinical trial, based in Sca-1 expressing cells, named 
CArdiosphere-Derived aUtologous stem Cells to reverse ventricular dySfunction (CADUCEUS), 
demonstrated to improve the health status of myocardial infarcted patients mainly due to an 
increase of the viable myocardium and decrease in the scar formation (13). 
Despite the existence of empirical data supporting each hypothesis, it is yet unclear, which is the 
most prominent source of new cardiomyocytes. However, and regardless the adopted premises, 
it is unanimously accepted that cardiomyocyte renewal is insufficient to assure functional 
restoration of the adult heart following MI. Hence, biomedical cardiovascular community is 
actively engaged in the development of therapeutic alternatives that envisage the generation of 
new cardiomyocytes in adequate numbers to re-establish the contractile capacity of the 
damaged heart. 
5.2. The Phylogenetic Axis of Cardiac Regeneration 
Regeneration, the ability to restore a lost body part, is a common phenomenon, widely 
disseminated in metazoans, that can occur at different biological levels (14) (Figure 2).  
In a broad perspective regeneration occurs by the de novo synthesis of functional tissue through 
recapitulation, to a varying extent, of the embryonic program that gave rise to the original tissue 
(15). Numerous efforts have been employed to identify similarities between regenerative 
responses observed in several animal models, aiming at targeting the molecular and biological 
players transversal to such phenomena (16). The comparison of embryonic (scar-free healing) 
and adult (scar-formation) response to skin wounds allowed Ferguson and colleagues to 
determine the levels of morphogens present in scar-free conditions. More impressively, 
restitution of those levels in adults, preceding injury, resulted in scar-free wound healing 
resembling the embryonic response (17). 
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Figure 2 – Biological organization of regeneration. Adapted from (14). 
Apart from the planarian (Planaria sp.), that has the extraordinary ability of regenerate entire 
organisms from tissue fragments (18), the most conspicuous evidence of regeneration is the 
restoration of whole body parts, often lost due to sublethal predation, the most common cause 
of tissue loss in nature (14). In vertebrates, whole-body regeneration is exclusive of amphibians, 
reptiles and fish, and therefore model-systems representative of these animal classes have been 
the subject of numerous studies regarding regeneration. In fact, the first evidence of heart 
regeneration was demonstrated in zebrafish (Danio rerio). After surgically resecting 10 to 20% 
of the adult ventricle myocardium in the apex region, the heart progressively restores the lost 
tissue within 60 days (19). Initially a blood clot is formed which is gradually replaced by newly 
formed cardiomyocytes, restoring the contractility to the original levels. Cre-Lox transgenic 
zebrafish have provided additional evidence that the regenerative response encompasses 
dedifferentiation and proliferation of pre-existing cardiomyocytes (20).  
Recently, cardiac regenerative potential of zebrafish was further demonstrated in different 
injury models. Cryoinjury of the ventricle was used to test whether zebrafish hearts would also 
recover from ventricular necrotic lesions. In fact, complete heart recovery by means of 
cardiomyocyte proliferation and invasion to the injury site was revealed (21). Concordantly, 
after genetic depletion of more than 60% of the ventricular myocardium, due to the induction 
of diphtheria toxin A chain (DTA) expression in cardiomyocytes, zebrafish hearts are still able to 
recover within several days by cardiomyocyte proliferation (22). 
Urodele amphibians, which include newts and salamanders, also display heart regeneration 
upon cardiac injury. Alike zebrafish pioneering work, after surgical resection of the ventricle apex 
of axolotl Amblystoma mexicanum, a blood clot is formed to prevent an extensive blood loss, 
followed by the establishment of a strong inflammatory response that is reduced overtime while 
tissue recovery is achieved by cell-cycle re-entry of pre-existing cardiomyocytes (23). The cardiac 
regenerative capacity of urodeles was further confirmed by applying a different injury model to 
newts while obtaining a similar regenerative response (24). 
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Evidence that the mammalian heart might also display a regenerative injury response was 
demonstrated in 2011 by Sadek’s team, using the mouse as a model-system. Contrarily to lower 
vertebrates, murine cardiac regenerative response was described as transient given that after 
surgical apex resection in 1 day old animals (P1), hearts progressively restored the lost tissue, 
however, when the same procedure was performed at P7, hearts did not recover and developed 
significant fibrosis (Figure 3). Hence, while the heart’s injury response at P1 is characterized by 
proliferation of pre-existing cardiomyocytes, response at P7 resembles the reparative response 
of adult mammals to MI, i.e. formation of a fibrotic non-functional scar (25). 
In addition to the apex-resection model, the same group and an independent group established 
the neonatal MI model, thus confirming that the mammalian heart could also regenerate, in a 
ischemic senario (26–28). P1 mice were subjected to MI by ligation of the left descending 
coronary arthery. This procedure induced extensive myocardial necrosis and systole 
dysfunction. However, faitfully to the apex-resection model, the heart was able to fully recover 
within 21 days by proliferation of the preexisting cardiomyocytes (28, 29). More importantly, 
the authors came forward with a mechanistic explanation for the very low rates of proliferating 
cardiomyocytes and subsequently to the loss of cardiac regeration from P7 onwards. The 
inhibition of miR-15 family of microRNAs, from an early postnatal age until adulthood, augments 
the number of proliferating cardiomyocytes in the adult heart and to an improvement on left 
ventricular systolic function of adult myocardial infarcted hearts (26, 29), therefore implicating 
this microRNAsin the neonatal loss of cardiac regenerative capacity. 
Despite evident phylogenetic distance between mammals, fish and amphibians, the main 
hallmarks of the heart regenerative course seem to be conserved, namely the formation of a 
blood clot and establishment of a strong inflammatory response, which are gradually replaced 
by newly contractile myocardium, arising from pre-existing cardiomyocytes. 
Figure 3 – Schematic representation of the ontogenic-specific heart-response to injury, characterized by main predominance of 
regeneration in the first post-natal week (regardless of the used injury model) in contrast to the well-reported reparative 
response of the adult heart to injury 
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Curiously, the loss of cardiac regeneration in neonatal mice coincides with physiological 
cardiomyocyte maturation that occurs post-birth. In fact, at this timeframe, i.e. in the first week 
post-birth, there is a switch from hyperplasic to hypertrophic growth concomitant with 
cardiomyocyte binucleation (in rodents) (30). 
Recently, close association between immune response and mammalian cardiac regeneration 
has been demonstrated. First, the inflammatory response is of great relevance given the 
necessity to remove cell debris. Furthermore, macrophages and other immune cells produce 
soluble factors that may influence other cell types. In fact, macrophages from regenerative (P1) 
and reparative (P14) hearts exhibit different molecular signatures, e.g. P1 macrophages express 
pro-angiogenic cytokines, which are crucial for successful tissue restoration. More impressively, 
neonatal regenerative response is halted following specific macrophages ablation (31) and thus 
rendering the immune modulation as a novel objective for newly developed clinical alternatives. 
5.3. The Downfall of the Paradigm 
Since Sadek’s team breakthrough, neonatal regenerative capacity of the mouse heart has been 
fully accepted and established, as such that his work has been cited over 200 times. 
However, in 2014 and therefore during the realization of this work, the controversy was settled 
when Andersen et al., while attempting to establish the neonatal heart injury in an inbred mouse 
strain, obtained and reported no evidence of complete regeneration (32). These authors 
documented a strong inflammatory response in the injury site, followed by massive collagen 
deposition. Additionally, resected hearts were shown to be smaller and with reduced 
cardiomyocytic proliferation and vascularization when compared to sham-operated controls. 
This deceptive outcome has created doubts concerning the reproducibility of the neonatal injury 
model and on the ability of neonates to regenerate their hearts. In our perspective the concept 
of ”complete regeneration” is rather unclear, so more important that the idea of neonatal full-
apex restoration is the ability of neonates to respond to injury by reactivation of neomyogenic 
mechanisms. In line with this, it is crucial to clarify whether this is an appropriate model to 
dissect mechanistic aspects underlying the activation and proliferation of cardiomyocytes that 
can be relevant for the implementation of therapeutic alternatives for adult-heart repair. 
5.4. The role of Cardiac Fibroblasts and of Extracellular 
Matrix in Response to Injury 
The heart is a complex organ, composed by several cell types, which include: cardiomyocytes; 
vascular elements (e.g. smooth muscle and endothelial cells) and cardiac fibroblasts (33). 
Indeed, although cardiomyocytes occupy the majority of heart’s volume, the most common cell 
type are cardiac fibroblasts (34, 35). The specific contribution of each cardiac cell, as well as of 
their interstitial surroundings, i.e. extracellular matrix (ECM), to the injury response observed in 
the neonatal heart is yet to be determined. 
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Cardiac fibroblasts and fibroblasts, in 
general, have been considered the 
main producers of ECM. In addition 
cardiac fibroblasts also produce and 
secrete metalloproteinases (MMPs) 
that are responsible for ECM 
degradation. Importantly, the 
dynamic equilibrium of the ECM 
composition modulates the 
behaviour of neighbouring cells (36, 
37). 
The role of cardiac fibroblasts in 
heart remodelling following MI has 
been meticulously scrutinized 
(Figure 4). 
Scarcity of oxygen and nutrients 
inherent to myocardial ischemia 
leads to massive cell dead and, in 
turn, necrotic/apoptotic cells release 
dead signals, which recruit immune 
cells to the injury site (38). Hence, 
after ligation of the left anterior descending coronary artery of adult mice, infiltration of 
neutrophils/macrophages is evident within the first 4 days (39). 
Along with inflammatory cells, cardiac fibroblasts migrate to the damaged tissue and proliferate 
massively and a fraction differentiates into myofibroblasts. These are recognizable by expression 
of smooth muscle cell markers, such as α-smooth muscle actin (αSMA) and by displaying 
spontaneous contractions, which are thought to be involved in appropriate wound closure and 
structural integrity of healing scars (40). These cells have a direct role in the recruitment of newly 
inflammatory cells to the damaged tissues through chemokine secretion (33). Myofibroblasts 
and fibrosis have been classically associated (41) since this cell type and also resident fibroblasts 
are responsible for abundant secretion of collagen type I and III in the injury site (42). The 
accumulation of collagen is the foundation of a stiffer and dense ECM, also known as fibrotic 
scar, which is completed within 21 days post-MI. (37, 39, 43). 
Indeed, the development of a fibrotic scar constitutes a quick and efficient response to trauma 
in the sense that is responsible for structurally supporting the compromised heart. 
Notwithstanding, once it is non-functional, as it is virtually stripped of cardiomyocytes, cardiac 
function is significantly affected. 
The role of cardiac fibroblasts in neonatal cardiac injury has never been ascribed. The transient 
nature of the regenerative response can be explained by fluctuations in the population of 
resident cardiac fibroblasts after birth. Nevertheless, several lines of evidence suggest that 
fibroblasts may be a key player in this process. Indeed, following birth cardiac ECM suffers a 
major transition in terms of biochemical composition that impacts on the heart´s mechanical 
properties (in detail in Section 5.). These alterations suggest post-natal phenotypic alterations 
Figure 4 – The diversity of functions of cardiac fibroblasts in response 
to myocardial infarction. Cardiac fibroblasts mediate injury response 
either through secretion of paracrine factors, differentiation into 
myofibroblasts and ECM modulation. Adapted from [19]. 
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on the fibroblast population/s. Our working premise is that the latter may have a direct impact 
on cardiomyocytes behaviour, imposing a swift on cardiomyocyte phenotype from hyperplasic 
to hypertrophic growth. In fact, immature embryonic cardiac fibroblasts were shown to induce 
cardiomyocyte proliferation via β1-integrin signalling, whereas mature adult cardiac fibroblasts 
enhanced cardiomyocyte maturation, namely by stimulating hypertrophy (36).  
The main limitation of studying cardiac fibroblasts is the absence of a reliable fibroblast marker. 
Although some proteins, e.g. fibroblast specific protein 1 (FSP1) (44), periostin (45), discoidin 
receptor domain 2 (DDR-2) (46), transcription factor 21 (TCF-21) (47), CD90 (Thy-1) (48) have 
been used for prospective identification of fibroblasts, there are several advantages and 
limitations associated with each marker, which highlights the need of carefully reviewing the 
conclusions drawn by their usage. 
The ECM is currently defined as the extracellular portion of a multicellular structure that 
provides structural and biomechanical support to cells. ECM can be divided into two categories: 
the basement membrane and stromal/interstitial matrix. The first consists in a thin layer of 
molecules that surround and support cells and bridges the cellular compartment with the 
respective stromal matrix. Once it is this type of matrix that is in touch with cells, it is this subtype 
that has more impact on cell behaviour and function (49). The stromal matrix is responsible for 
the main tissue structural support due to the large amount of fibrous molecules in its 
composition (50). 
The ECM is recognized as a bioactive unit that modulates neighbouring cell behaviour either 
directly, by cell-matrix interactions mediated by integrins, or indirectly, by paracrine effects of 
molecules sequestered in the ECM network (51). Additionally, ECM is a dynamic structure that 
is affected by microenvironmental stimuli, such as during development and following tissue 
injury, by adjusting the composition, stiffness, organization and, ultimately, the function. ECM 
plasticity certainly accounts for the fact that ECM is critical for organ formation and repair, which 
has been recognized for a long time (52, 53). 
The cardiac ECM is composed by several different types of molecules, including different types 
of collagen, a variety of glycoproteins and proteoglycans. Cardiac fibroblasts and vascular 
smooth muscle cells are responsible for the production of the most common cardiac ECM 
proteins such as collagen I and III. In turn, cardiomyocytes produce essentially the proteins 
present in their basal lamina (e.g. collagen IV and VI, laminin and proteoglycans) (54, 55). 
However, after birth there is a significant decrease on the levels of fibronectin and elastin (56) 
and also a dramatic change in the elastic modulus of epicardium following birth from 12 kPa to 
39kPa (57). Consistently, during aging the levels of collagens are enriched (58). This correlates 
with a decrease in the myocardial elasticity, compromising to a limited extent, the cardiac 
function (59). In our perspective these changes throughout ontogeny, and specifically after birth, 
may be determinant to the transition between regenerative and reparative behaviour of the 
heart. 
In fact, several evidences demonstrate that ECM is essential for the regenerative response 
generated upon cardiac injury. Following apex-resection of adult zebrafish, epicardial cells 
dynamically produce fibronectin. Concomitantly, cardiomyocytes augment the levels of α5 and 
β3 integrins that are constituents of fibronectin receptors, which leads to specific triggering of 
integrin signalling pathways and cardiomyocyte proliferation and migration (60). Moreover, the 
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authors, by using a transgenic line that enables a heat-inducible expression of a dominant-
negative human fibronectin fragment, showed that in the absence of fibronectin no 
regeneration was observed. 
Notwithstanding, transforming growth factor-β (TGF-β) ligand and receptors, which are induced 
in fibroblasts and cardiomyocytes following cryoinjury, are also required for heart regeneration 
in zebrafish (Figure 5). 
 
Figure 5 – The role of TGF-β signalling pathway in zebrafish heart response to cryoinjury. Cardiomyocyte death leads 
to an inflammatory response and migration of leukocytes and fibroblast-like cells actively expressing TGF β (A). Once 
the majority of death tissue is cleared, a TGF-β signalling-mediated collagen-rich extracellular matrix is formed (B). As 
scaring begins TGF-β induces the proliferation of neighbouring cardiomyocytes that migrate to the injured area, 
replacing the fibrotic scar (C). Cardiomyocytic proliferation seems to be Tenascin-C dependent, mainly due to its anti-
adhesive properties(61)(61)(61)(61)(61)(61)(61)(61)(61)(61)(61)(61)(61)(61)(61). Adapted from (61) 
A recent study in the adult newt (Notophthalmus viridescens) demonstrated that, following 
apex-resection tenascin-C, hyaluronic acid and fibronectin are up-regulated, which precedes the 
proliferation and migration of cardiomyocytes to the injured area. In order to address whether 
these ECM components were having an instructive role in cardiomyocytes, primary newt 
cardiomyocytes were plated on regeneration-specific ECMs. In fact, cardiomyocytes displayed 
the highest proliferation levels in the presence of Tenascin-C, suggesting that this protein is 
directly or indirectly promoting cardiomyocyte proliferation (62). 
The herein MSc dissertation will evaluate the dynamics of cardiac ECM and its main producer, 
the cardiac fibroblast, during regenerative and reparative ontogenic stages as well as in response 
to neonatal heart injury. We anticipate that fibroblast/ECM-specific regulators of cardiomyocyte 
proliferation/maturation will be identified which may hold great potential for treatment of 
cardiac pathologies associated with cardiomyocyte loss. Moreover, by independently 
establishing the neonatal apex-resection injury model we expect to provide empirical evidence 
aiming at clarify whether there is indeed activation of regenerative processes in the neonatal 
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murine heart following apex-resection, namely through the reactivation of cardiomyocyte 
proliferation. 
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6.1. Animals 
All animal experiments were performed in accordance with IBMC.INEB Animal Ethics Committee 
and to DGAV. Humane endpoints were performed in accordance with the OECD Guidance 
Document on the Recognition, Assessment, and Use of Clinical Signs as Humane Endpoints for 
Experimental Animals Used in Safety Evaluation (2000). C57BL/6 mice from embryonic day (E)17 
to 8 weeks were used in this study. 
6.2. Neonatal Apex-Resection and Sham-Surgery 
The neonatal injury model consists in apex surgical resection of post-natal day (P)2 C57BL/6 
mice. Animals were anesthetized by hypothermia during approximately three to four minutes 
to cease respiratory movements and heart contractions and lose the paw withdrawal reflex. 
Animals were laid in lateral decubitus position, exposing the left-side flank. After animal 
immobilization with sealing tape, the skin was cut and muscle fibres disrupted until ribs were 
observed. The thoracic cavity was opened in the 4th intervertebral space and the left ventricle 
apex cut with fine scissors. The thorax was closed by 6-0 absorbable suture (Coated Vicryl 
Ethicon) and skin closed by tissue adhesive (3M VentbondTM). The animal recovered under an 
infrared lamp and was subjected to stimulation by tightening the paw. The surgery was complete 
when the animal regained regular breathing. After operating all animals from the same litter, 
neonates were returned to the progenitor cage given t they rely on the mother for temperature 
regulation and food. During all the procedure, except throughout surgery, neonates were 
warmed by warming pads and infrared light. Sham mice underwent the exact same procedure 
with the exception of apex-resection.  
6.3. Histological Analysis 
Hearts were harvested at 0, 2, 5, 7, 14, 21 and 62 days post-apex resection (dpr)). Until day 14 
the pups were sacrificed by decapitation, using the single movement of a scissor. For longer 
timepoints, animals were sacrificed by cervical dislocation. Hearts were submersed in phosphate 
buffer saline (PBS) and fixed in 10% formalin neutral buffer (VWR BDH & Prolabo) either during 
24 hours at room temperature or 48 hours at 4ºC. For paraffin embedding, hearts were 
processed during a total time of 12 hours in an automated system through successive PBS 
washes, crescent series of alcohols (Aga), Clear Rite 3® (Richard-Allan Scientific) and Shandon 
Histoplast (Thermo Scientific) at 56ºC. Hearts were included in paraffin and sectioned 
(microtome RM2255, Leica) longitudinally (3 µm sections). For representative sampling of the 
heart 10 series of cuts equally distanced were obtained. The distance between sections was 
specific for each ontogenic stage (0 dpr – 50 µm; 2 dpr – 30 µm; 5 dpr – 100 µm, 7 dpr – 40 µm 
and 14 dpr – 100 µm; 21 dpr – 70 µm; 62 dpr – 100 µm). Sections were dewaxed and rehydrated 
prior to Hematoxylin-Eosin (HE) and modified Masson’s Trichrome (MT) stains. Briefly, for HE 
stain, sections were incubated 5 minutes in Gill’s Hematoxylin (GHS232, Sigma-Aldrich), 
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followed by bluing in 0,5% ammonia for 4 seconds or 2 minutes in tap water. Sections were then 
dehydrated through graded alcohols and incubated for 2 minutes in alcoholic eosin (Leica & 
Thermo). The MT was performed according to the Trichrome (Masson) Stain kit (HT15-1KT, 
Sigma-Aldrich), with the following modifications: nuclei were prestained with Celestine Blue 
solution after staining with Gill’s Hematoxylin and incubation for 1 hour in aqueous Bouin 
solution to promote uniform staining. Sections were diafanized in xylene and mounted in DPX 
Mountant for histology (06522, Sigma-Aldrich®). Whole-heart images were acquired in a 
Olympus SZX10 stereomicroscope. High-magnification images were acquired with the inverted 
fluorescence microscope Axiovert 200 Motorized and an AxioCam HRm camera (Zeiss, 
Oberkochen, Germany). 
6.4. Functional Characterization 
Animals at 21 dpr (n=4) were subjected to echocardiography using the Vevo2100 system and a 
40MHz probe. Anaesthesia was induced in a chamber filled with 5% isoflurane (IsoVet, Braun). 
and verified by loss of body posture and paw withdrawal test. The animal was transferred to a 
37ºC heated support and the state of anaesthesia was maintained through a face mask (1.5% 
isoflurane). Animal fur was shaved and mice paws were placed over sensors and in contact with 
an electric-conductive gel to monitor heart and respiratory rates. The temperature was assessed 
using a rectal probe. This system assists on the calculation of the heart ventricle wall thickness 
and the diameter of the ventricular chambers during the diastole (LVIDd) and the systole (LVIDs). 
These measurements were done to calculate the ejection fraction (EF) and fraction shortening 
(FS) and thus predict the systolic function of the animal. By comparing these factors on sham 
operated and injured hearts the degree of functional restoration was ascertained. Two-
dimensional (2D) mode images of short-axis (SAX) and parasternal long-axis (PSLAX) were 
acquired to position the Motion-mode (M-mode) cursor. To evaluate LV structural changes, 
several parameters from M-mode were measured (that is, the LV internal diameter at diastole 
(LVIDd) and at systole (LVIDs). Left ventricular ejection fraction (EF) and fraction shortening (FS) 
were calculated as an index of systolic function: FS (%) = ((LVIDd - LVIDs)/LVIDd) × 100 and EF 
(%) = ((LVIDd3 – LVIDs3)/LVIDd3) × 100. The same parameters were measured on nonmanipulated 
healthy animals (n =3). 
6.5. Immunofluorescence 
To further characterize apex-resected and sham-operated hearts by immunofluorescence, these 
were embedded for cryosectioning. Tissue processing involves 3 consecutive submersions (each 
during 24 hours at 4⁰C) in different solutions: 0,2% Paraformaldehyde in 0,12M phosphate 
buffer;  4% sucrose in 0,12M phosphate buffer and 15% sucrose in 0,12M phosphate buffer. A 
fourth incubation is performed in 15% sucrose and 7,5% gelatin in 0,12M phosphate buffer with 
during 1 hour at 37⁰C. Hearts were transferred to molds containing the last solution (warmed) 
and placed on top of dry-ice-chilled 2-methylbutane (GPR Rectapur, VWR). Frozen hearts were 
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stored at -80⁰C before being cut from one end to the other into 5μm sections using the 
refrigerated microtome (Microtom HM 550, Thermo Scientific). 
Cryosections were used to evaluate protein expression. When targeting epitopes that required 
cell membrane permeabilization, sections were treated with 0.2% Triton X-100 (for 
intracytoplasmic motifs) or with 1% Triton X-100 (for nuclear motifs). Tissue sections were 
blocked for 1 hour in 4% FBS and 1% bovine serum albumine (BSA). If the primary antibody was 
produced in mouse, the M.O.M.TM Immunodetection Kit (Vector Lab) was applied to enable 
blocking of endogenous Fc receptors that could be recognized by the secondary antibody (63). 
Incubation with primary antibody was performed in a humidified chamber 2 hours at room 
temperature (RT) or, alternatively, overnight at 4ºC. Following the primary antibody incubation 
sections were incubated with the secondary antibody (RT) during 1 hour. In order to amplify the 
fluorescence intensity of several antibodies, two streptavidin conjugated fluorophores were 
used, which were: Streptavidin conjugated with Alexa 555 (S32355, Invitrogen), at 1:500 dilution 
and Streptavidin conjugated with Allophycocyanin (APC) (SA1005, Life Technologies), at 1:100 
dilution. Sections were mounted with FluoroshieldTM with DAPI (F6182, Sigma-Aldrich) and were 
observed in a Zeiss Axiovert 200M, an inverted fluorescence microscope. Fluorescent images 
were captured using a monochromatic camera (AxioCam MNC, Carl Zeiss). 
 
Table 1 – List of primary antibodies used and specification of the working dilution. 
Primary Antibody Dilution Reference 
Sarcomeric-αActinin (Mouse IgG) 1:400 A7811, Sigma 
Tcf21 (Rabbit IgG) 1:100 ABIN1385977, Antibodies-Online 
Vimentin (Mouse IgG1/K) 1:50 MS-129-P, Thermo 
Vimentin (Mouse IgM) 1:8 40E-C, D.S.H.B. 
CD31 (Goat IgG) 1:250 sc-1506, Santa Cruz Biotechnology 
CD45 (Goat IgG) 1:100 AF114, R&D 
Alpha-Smooth Muscle Actin (Mouse IgG) 1:400 A5228, Sigma 
Collagen IV (Goat IgG) 1:50 AB769, Millipore 
Collagen IV (Rabbit IgG) 1:100 AB756P, Chemicon 
PH3 (Rabbit IgG) 1:250 #3377, Cell Signaling 
Fibronectin (Rabbit IgG) 1:400 F-3648, Sigma 
Laminin (Rabbit IgG) 1:400 L9393, Sigma-Aldrich 
Cleaved Caspase-3 (Rabbit IgG) 1:100 #9661, Cell Signaling 
Tenascin (Rat IgG) 1:100 LAT-2, Sonnbg 
PLVAP (Rat IgG) 1:8 MECA-32, D.S.H.B. 
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Table 2 - List of secondary antibodies used and specification of the working dilution 
Secondary Antibody Dilution Reference 
Alexa Fluor 488 Donkey anti Mouse IgG 1:1000 A-21202, Invitrogen 
Alexa Fluor 568 Donkey anti Rabbit IgG 1:1000 A-10042, Invitrogen 
Alexa Fluor 568 Donkey anti Goat IgG 1:1000 A-11057, Invitrogen 
Alexa Fluor 488 Goat anti Mouse IgG 1:1000 A11017, Molecular Probes 
Alexa Fluor 568 Goat anti Rat IgG 1:1000 A11077, Molecular Probes 
Alexa Fluor 633 Goat anti Rabbit IgG 1:1000 A21070, Molecular Probes 
Alexa Fluor 488 Donkey anti Rat IgG 1:1000 A-21208, Invitrogen 
Biotinylated Donkey anti Goat IgG 1:250 A16009, Life Technologies 
Biotinylated Donkey anti Rabbit IgG 1:250 A16033, Life Technologies 
 
6.6. High Content Screening (HCS) 
The proliferative response of neonatal murine hearts following injury was evaluated using the 
GE IN Cell Analyzer 2000. Whole-heart images at 7 dpr and dps were obtained by the assembly 
of individual pictures at 20x magnification. Using IN Cell Investigator software, the total number 
of cells was determined (using DAPI as proxy). Mitotic cells were ascertained by the co-
localization of DAPI and PH3, whereas mitotic cardiomyocytes by the co-localization of DAPI, 
PH3 and sarcomeric-αActinin.  
6.7. Flow Cytometric profile of Cardiac Populations 
Flow cytometry was performed to characterize cardiac fibroblast populations, selected on the 
basis of CD90 expression, from E17 to adulthood. This characterization was also extended to 7 
dpr/dps animals.  
Cardiac cells were isolated by digestion of cardiac tissue fragments with crude collagenase 
(C2139, Sigma-Aldrich®) at 200μg/ml concentration and DNase (A3778, VWR) at 60U/ml in 
hanks balanced salt solution (HBSS) (H9269, Sigma-Aldrich®). Collagenase digestions were 
performed during 15 min at 37ºC until no tissue was observed by visual inspection. After each 
digestion, the suspension was decanted, the media collected (cellular portion) and a new 
collagenase/DNase solution was added to the remaining tissue fragments. The collected cell 
suspension was mixed with HBSS with 10% FBS to neutralize enzymatic activity and was kept on 
ice. The collected cellular fraction of each digestion were combined and washed in FACS medium 
(0.01% Na-azide 1% FBS in PBS). Cells were evenly distributed for each staining in a round-
bottom multiwell plate. After a first wash in FACS buffer, cells were incubated during 25 min 
with the antibody cocktail on ice and in the dark. In case of biotinylated primary antibodies were 
METHODS| 19 
 
 Vasco S. Pinto | THE DYNAMICS OF FIBROBLASTS/ECM IN NEONATAL CARDIAC INJURY 
used cells were incubated in the appropriate conjugated streptavidin for 15 min on ice and in 
the dark. Cells were washed twice in FACS and transferred to FACS tubes 
In order to exclude nonviable cells from the analysis, 0.5% of propidium iodide (P4170, Sigma-
Aldrich) was added to the cell suspension 1-2 min prior to analysis.  
To analyse the nuclear proliferative marker Ki-67, cells were fixed and permeabilized prior to 
staining according to Foxp3 Staining Buffer Set (00-5521-00, eBiosciences) and Permeabilization 
Buffer (00-8333, eBiosciences). 
Fifty thousand events (of appropriate size and complexity) per staining were acquired in the 
cytometer FACS Canto II (BD Biosciences). Subsequent analysis and graphing were executed in 
FlowJo_VX software.  
 
Table 3 – List of antibodies and streptavidins used in Flow Cytometry and specifications of the working dilution. 
Antibodies Dilution Reference 
CD31-PE (FL2) (RatIgG2a) 1:100 553373, BD Pharmingen 
CD31-PeCy7 (Rat IgG2a) 1:100 25-0311, eBiosciences 
CD31-APC (Rat IgG2a) 1:400 102516, Biolegend 
CD45-PE (FL2) (Rat IgG1) 1:100  22150456S, Immunotools 
CD45-PeCy7 (Rat IgG2b) 1:100 25-0451, eBiosciences 
CD45-Biotinylated (Rat IgG2b) 1:500 103103, Biolegend 
TER119-PE (Rat IgG2b) 1:100 116208, Biolegend  
TER119-PeCy7 (Rat IgG2b) 1:100 116221, Biolegend 
TER119-Biotinylated (Rat IgG2b) 1:100 116203, Biolegend 
CD90.2-PE (Rat IgG2a) 1:100 553014, BD Pharmingen 
CD90.2-FITC (Rat IgG2b) 1:100 553013, BD Pharmingen 
CD29-Pacific Blue (Armenian Hamster IgG) 1:100 102224, Biolegend 
CD140a-APC (FL4) (Rat IgG2a) 1:100 135907, Biolegend 
Flk-1-APC (FL4) (Rat IgG2a) 1:100 560070, BD Pharmingen 
Sca-1-PeCy7 (Rat IgG2a) 1:100 108114, Biolegend 
Sca-1-FITC (FL1) (RatIgG2a) 1:100 11-5981, eBiosciences 
CD44-APC/Cy7 (Rat IgG2b) 1:100 103027, Biolegend 
CD105-PE (FL2) Rat IgG2 1:100 120407, Biolegend 
CD106-PE (Rat IgG2a) 1:100 105713, Biolegend 
CD140b-PE (FL2) (Rat IgG2a) 1:100 12-1402, eBiosciences 
Streptavidin-APC  1:800 554067, BD Pharmingen 
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6.8. Statistical Analysis  
Data statistical analysis was performed with the IBM SPSS Statistics 20 software. Shapiro-Wilk’s 
test was used to evaluate if the data displayed a normal distribution. If so, the homoscedasticity 
of the data was tested by Levene’s test. These results defined the statistical test(s) used further. 
Normal distributed and homocedastic data were tested with parametric tests (independent 
samples T Test for 2 groups or one-way ANOVA for 3 or more groups). Non-normal distributed 
and/or heterocedastic data were tested with non-parametric tests (Mann-Whitney U Test for 
two groups or Kruskal-Wallis one-way analysis of variance for 3 or more groups). The statistical 
significance level chosen for all statistical tests was p<0.05. 
 
 7. Results 
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7.1. Implementation of the Neonatal Apex-Resection 
Model 
In order to study the molecular mechanisms underlying cardiac regeneration we established the 
neonatal apex-resection model developed by Porrelo et al. (25), at our laboratory (Figure 6). 
Differently, we used the inbred C57Bl/6 strain instead of the outbred ICR/CD-1 strain originally 
used and post-natal (P2) mice instead of P1, since were still within the reported regenerative 
period (25). Survival rates were approximately 70% ± 22% post-surgery and 38% ± 36% after 
maternal cannibalism. Sham-operated animals, subjected to the same surgical procedure but 
without apex resection, were used to exclude misleading effects of the surgery. The survival rate 
in this group was significantly higher (approximately 85% ± 15% post-surgery and 55% ± 27% 
after maternal cannibalism).  
Hearts of non-manipulated animals, sham-operated and apex-resected animals were harvested 
at different time-point to validate and characterize the injury model. 
Histological characterization (Figure 7) demonstrated the reproducibility of the surgery as the 
majority of the lesions reached the cardiac lumen. In the first 48 hours post-resection (dpr), a 
large blood clot is formed (yellow and red staining in Masson’s Trichrome and Hematoxilin-Eosin 
stain, respectively) to prevent extensive haemorrhage, as containment response, following 
exposition of the lumen after resection. As soon as 48 hours and up to 7 dpr an inflammatory-
like infiltrate is observed at the injury site, which is replaced by a collagen rich-extracellular 
matrix (blue staining in Masson’s Trichrome staining) from 14 dpr onwards. This scar region is 
still noticeable at 60 dpr which was the last time-point analysed. Of note, the observed collagen-
based scar does not seem to extend to the whole apex but rather to the most central sections 
in which the apex is observed. Additionally, collagen rich adhesions become apparent in the 
epicardial surface of the cardiac apex at 5 dpr and were still present at 60 dpr. These adhesions, 
that tightly attached the heart to the ribs (data not shown), and are a common consequence of 
open-heart surgery, result from the inflammatory reaction created on outer surface of the heart. 
Overall, we observe an accumulation of fibrotic tissue in the myocardium and externally to the 
epicardium, which differs reported observations of a regenerative response with minimal 
cardiac fibrosis (25). 
Functional characterization of the neonatal injury model was performed at 21 dpr and compared 
to sham-operated animals of the same time-point (Figure 8). The measures performed using M-
mode images of the short-axis (SAX) and parasternal long-axis (PSLAX) allowed the 
determination of ejection fraction and fraction shortening. These indicators of systolic function 
and the left ventricle internal diameter during systole (LVIDs) were not statistically different 
between groups. However, left ventricle internal diameter during diastole (LVIDd) was increased 
in animals subjected to apex-resection (p-value < 0,05). These results demonstrate that tissue 
remodelling observed in the histological characterization, namely the apical collagen deposition, 
does not significantly impact on LV function. However, the differences in the LVIDd correlate 
well with a more round-shape anatomy observed in the apex-resected group (Supplementary 
Figure 1). 
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Figure 6 – Neonatal Cardiac Injury Model. After being anesthetized by hypothermia during 3 minutes, P2 C57BL/6 
mice are laid in lateral decubitus position. The skin is cut and muscle fibers disrupted until the ribs are visible (A-B). 
The heart is assessed by opening the thorax in the 3rd intervertebral space and the apex is cut (C-E). The suture 
comprises two surgeon’s knots that ligate the two separated ribs (F-G). The skin is glued using tissue adhesive (H) and 
respiratory and cardiac movements are recovered by subjecting the animal to heat produced by an infrared lamp.  
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Figure 7 – Histological Characterization of the Neonatal Cardiac 
Injury Model. Representative Masson’s Trichrome (MT) and 
Hematoxilin-Eosin (HE)-stained sections of apex-resected hearts at 
specific timepoints (0, 2, 5, 7, 14, 21 and 60 days post-apex 
resection (dpr)) Their specific non-manipulated controls (P2, P4, 
P7, P9, P16, P23 and P62) are also shown. Only central sections, in 
which the apex region was more evident, were selected to the 
panel. Low power images emphasize the morphological 
progression of the heart following injury. High power images, 
focusing apex-resected area, show that as soon as 0 dpr until 48 
hours post-surgery, a blood clot is formed (arrowheads). From 48 
hours and up to 60 dpr, extensive tissue remodelling is evident at 
the apex region, culminating in the formation of a collagen-rich 
fibrotic scar (blue) that occupies part of the apex region (asterisk). 
Tissue adhesions are also visible in the epicardial surface of the 
heart in injured region. (arrows) Scale-bars: 1 mm (0, 2, 5, 7, 14, 21 
dpr), 2 mm (60 dpr). 
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Figure 8 – Functional Characterization of the Neonatal Cardiac Injury Model. Analysis of ejection fraction, fraction shortening, left ventricle 
internal diameter in diastole (LVIDd) and sistole (LVIDs), calculated in short-axis (SAX) and parasternal long-axis (PSLAX) view, of apex-resected 
mice (21 dpr, n=4) and sham-operated controls (21 dps, n=3). Apart from the LVIDd (p-value < 0,05), no differences were detected between apex-
resected and sham-operated animals. Values are presented as means ± standard deviation (SD).  
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7.2. Dynamics of the Cellular and Extracellular Compartments 
Following Apex-Resection 
Several studies, namely in lower-vertebrates, have been focusing the role of ECM in heart regeneration. 
Here we ascribed the expression pattern of selected ECM proteins, namely fibronectin, tenascin-C, 
laminin and collagen IV. Additionally, we co-localized these proteins with different cardiac-cell markers, 
aiming at inferring which cell type is responsible for the production and secretion of such proteins (Figure 
9). Therefore, we analysed the expression of sarcomeric-alpha-actinin (cardiomyocytes), CD45 
(hematopoietic cells), alpha-smooth muscle actin (smooth muscle cells/myofibroblasts), CD31 
(endothelial cells) and vimentin (fibroblasts).  
Hematopoietic cells (CD45-expessing cells) are present from 0 dpr and cell frequency increases until 5dps 
while, from this time-point onwards, a dramatic decrease of CD45-expressing cells is observed which may 
relate with the resolution of inflammation. Differently, α-SMA- and vimentin-expressing cell rates steadily 
increase until 7 dpr, most likely representing the proliferation and differentiation of cardiac fibroblasts 
into myofibroblasts. Concordantly to what is described in literature for zebrafish and urodele amphibians, 
we observed increased deposition of fibronectin (FN) and tenascin-C (TN-C) in the outer surface of the 
apex-resected area. This accumulation is already evident at 48 hours post-apex resection and remains 
elevated until 14 dpr for fibronectin and until 21 dpr for tenascin-C. An association between fibronectin 
and CD45 expression was observed until 5 dpr. However, from 7dpr onwards, fibronectin appears 
augmented in the vicinity of alpha-smooth muscle actin (α-SMA) expressing cells. This is suggestive of a 
double origin of fibronectin at the injury site i.e. primarily the fibronectin originates from the blood clot 
and infiltrating inflammatory cells, while after resolution of acute inflammation, de novo fibronectin 
production is assured by myofibroblasts. Regarding TN-C expression, despite accumulated in regions in 
which vimentin expressing cells appear more frequently (in the border zone of the resected apex), 
vimentin expressing-cells do not seem to be the major producers of this protein. Through the expression 
of sarcomeric-alpha-actinin (s-α-actinin) we were able to observe myocardial disruption caused by apex-
resection. However, as time progresses, there seems to occur a partial recovery of the myocardium. This 
is corroborated by the expression pattern of the basal lamina proteins laminin and collagen IV that 
normally form a sheath surrounding cardiomyocytes. At early time-points, there is a clear disturbance of 
the normal laminin and collagen IV expression patterns in the apex-resection area, which is almost 
recovered by 21 dpr. With regard to CD31 expression, we were only able to detect its presence on major 
vessels, and not on capillaries as was expected, in both injury- and sham-conditions which may relate to 
epitope masking due to fixation or the need for signal amplification.  
Subsequently, we aimed to ascertain if the expression of extracellular matrix was correlated with higher 
levels of proliferation/mitosis. We focused at 5 and 7 dpr once higher levels of FN and TN-C were detected 
at these time-points. Also, in the original report of the neonatal apex model the proliferation was highest 
at 7 dpr. Once the combination of antibodies was not compatible with the co-detection of FN, TN-C and 
PH3, we first verified that the expression pattern of FN and TN-C overlapped (Figure 10) and then the 
expression α-actinin was co-localized with either PH3 or fibronectin in adjacent sections. As we 
hypothesized, the frequency of mitotic cells is higher in the injury site and within tissue adhesions, and 
thereby, in regions of/adjacent to FN and TN-C accumulation. These findings are suggestive that FN and/or 
TN-C might be promoting cell proliferation in the neonatal injured heart.  
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 Figure 9 – Representative images of cardiac cells co-
localization with ECM components in the injury site at 
0, 2, 5, 7, 14 and 21 days post-apex resection.  The 
disruption of the myocardium caused by the apex-
resection is shown by αActinin staining and by the 
disorganized pattern of the basal lamina proteins 
laminin and collagen IV until 14 days post-apex 
resection. From 48 hours up to 21 days following apex 
resection the cellular and extracellular composition of 
the injured site is dramatically altered, culminating in 
the partial reestablishment of the removed myocardium 
at 21dpr. Scale-bars, 30 μm; n=3. 
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Figure 10 – Representative images of 
mitotic cells (PH3+) in the vicinity of 
extracellular matrix deposition 
(fibronectin and tenascin) at 5 and 7 
days post-apex resection. Scale bar, 
30 μm. n=2. 
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With the purpose of determining the levels of proliferation, in particular of cardiomyocytes, in injured vs 
sham-operated hearts 7 days after surgery, co-localization of DAPI, s-α-Actinin and PH3 was performed 
and, whole-heart images were obtained via the assembly of high-magnification images. With appropriate 
software, we determined the number of mitotic cells (co-localization of DAPI and PH3) and the number 
of mitotic cardiomyocytes (co-localization of DAPI, PH3 and s-α-Actinin). The results revealed that the 
number of mitotic cells per mm2, in the ventricles, is increased near the injury site, and therefore the 
analysis was restricted to the myocardial region bellow the papillary muscles (Supplementary Figure 3 and 
4). This analysis showed that the proliferation (Figure 11A) and in particular of cardiomyocytes (Figure 
11B), was increased in the apex-resected group when compared to the control, although this tendency 
did not reach statistical significance (p-value = 0,154 and p-value = 0,177, respectively). We consider that 
the statistical significance may be attained by increasing the numbers of analysed samples. This will also 
permit the identification of outliers in the sham operated group that may be generated as a result of 
unintentional scrapping of the myocardium during the disruption of the pericardium and that can activate 
injury mechanisms of cardiomyocytes proliferation as following apex-resection. 
  
 
 
 
 
 
 
 
 
 
Figure 11 – Proliferation on the ventricles (bellow papillary muscles) of apex-resected animals and sham-operated controls, 7 
days post-surgery. A – Number of mitotic cells per mm2 in the apex area. Despite the increased number of mitotic cells in the 7 
dpr, no significant differences were found between groups (p-value = 0,154). B - Number of mitotic cardiomyocytes (CM) per mm2. 
Despite the increased number of mitotic CM in the 7 dpr, no significant differences were found between groups (p-value = 0,177). 
n=4.  
7.3. Dynamics of Cardiac Fibroblast Populations Throughout 
Ontogeny and Following Apex-Resection 
With the aim at characterizing the cardiac fibroblast populations throughout ontogeny, we digested the 
heart to obtain a single-cell suspension that was subjected to immunolabeling, with an assortment of 
antibody to discriminate different cardiac populations, and further analysed by flow-cytometry. To 
exclude endothelial, hematopoietic and erythroid cells, antibodies against CD31, CD45 and TER119, 
respectively, were included in the analysis. Propidium iodide (PI) assisted on the exclusion of death cells, 
once live cells do not incorporate this compound. The triple negative population (CD31-, CD45- TER119- ) 
is the population selected for further analysis and is hereafter further called “the stroma” (Figure 12A). 
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Within this population, cardiac fibroblasts were identified on the basis of CD90 (Thy-1) expression (Figure 
12A and B). At the embryonic day (E)17 the amount of CD90 expressing cells in the heart is around 30%, 
this frequency highly increases following birth reaching above 50% at P2. The numbers of cardiac 
fibroblasts (CD90+) stabilizes at approximately 60% from P14 onwards. Despite the existence of a large 
variation on the levels of CD90 between embryonic (E17) and post-natal life (P2), this difference did not 
reach statistical significance. Significant differences were found between E17 and P10 (p-value < 0,05), 
E17 and P14 (p-value < 0,001); E17 and Adult (p-value < 0,01); P2 and P14 (p-value < 0,001), P2-Adult (p-
value < 0,05); therefore supporting the observed tendency for CD90+ increase throughout life. 
As previously mentioned, we analysed the expression of mesenchymal-associated markers and cell-
adhesion molecules together with CD90+ population, namely CD29 (Integrinβ1), Sca-1 (Stem Cell Antigen 
1), CD44, CD140a (PDGFRα), CD105 (Endoglin), CD106 (VCAM-1) (Figure 12C). Regarding the co-
expression of CD90 and CD29, the large majority of CD90 expressing cells express CD29 in all analysed 
ontogenic stages. Still, statistically significant differences were found between E17 and P10 (p-value < 
0,05), E17 and P14 (p-value < 0,05), P2 and P10 (p-value < 0,01), P2 and P14 (p-value < 0,001). The elevated 
frequency of CD29+CD90+ (>90%) casts doubt on the biological relevance of such small, though statistically 
significant, variations. 
Recently, our team (10, 64) and others (65, 66) showed that mesenchymal-affiliated markers are 
commonly expressed by heart-resident Sca-1+ progenitors and cardiac fibroblasts, reinforcing the impact 
of understanding the composition alongside the cardiogenic potential of the stromal cell compartment in 
the heart. We have analysed the frequency of Sca-1+ cells within the CD90+ population. Sca-1+CD90+ cells 
increase substantially throughout ontogeny, being almost negligible at E17/P2 while increasing to 30% 
and 70% at P14 and during adulthood, respectively. Indeed, statistically significant differences were found 
between E17 and P14 (p-value < 0,01), E17 and adult (p-value < 0,01), P2 and P14 (p-value < 0,001), P2 
and adult (p-value < 0,001).  
CD44 is a transmembrane glycoprotein that functions as cell-adhesion molecule, by tethering cells to 
extracellular ligands such as hyaluronic acid, but also participates in cell-signalling cascades (67). 
Additionally the expression of CD44 has been related to the differentiation of fibroblasts into 
myofibroblasts (68) and to fibroblast tissue-invasive capacity (69, 70). The percentage of CD44+CD90+ 
remained stable around 25% throughout ontogeny.  
During development, PDGFRα (CD140a) is required for epicardial-specification and epicardial derived cells 
epithelial-to-mesenchymal transition that gives rise to a population of cardiac fibroblasts. Indeed, loss of 
PDGFRα, results in a specific disruption of cardiac fibroblast development and subsequent absence 
PDGFRα+ fibroblasts cells in the myocardium (71). Our results, demonstrate that the levels of 
CD90+CD140a+ fibroblasts increases from 60% in E17 up to almost 90% in P14, while re-establishing 
throughout adulthood the expression levels observed at E17. Statistically significant differences were 
found between E17 and P10 (p-value < 0,01), E17 and P14 (p-value < 0,001), P2 and P14 (p-value < 0,001), 
P14 and adult (p-value < 0,01).  
Two other mesenchymal-associated markers have been included in this analysis, CD105 (endoglin) and 
CD106. The percentage CD105+CD90+ cells increases throughout ontogeny, being approximately 60% of 
at E17 and ranging between 80% from P2 to adulthood. Statistically significant differences were found 
between E17 and P14 (p-value < 0,05), E17 and adult (p-value < 0,05). Similarly, CD106+CD90+ became 
more frequent throughout ontogeny, starting at approximately 50% at E17 and stabilizing at 60-65% from 
P2 onwards. Significant differences were found between E17 and P2, P14, adult (p-value < 0,001), E17 and 
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P10 (p-value < 0,01). CD140b- (PDGFRβ) and Flk-1-expressing cells were also evaluated but negligible 
percentages were found within the CD90 cell-compartment (Supplementary Figure 2).  
We further analysed the proliferative behaviour of the stromal compartment (CD31-CD45-TER119-) 
throughout ontogeny, using the proliferation marker Ki67 (Figure 12D). Concordantly to what is described 
in literature, the number of proliferating cardiac cells declines considerably throughout ontogeny. At E17 
over 30% of the cells are proliferating while, this percentage progressively decreases reaching a minimum 
of 2-3% in the adult life. Statistically significant differences were found between E17 and P14 (p-value < 
0,01), E17 and adult (p-value < 0,001), P2 and P14 (p-value < 0,05), P2 and adult (p-value < 0,01). 
Within the proliferative compartment (CD31-CD45-TER119-Ki67+), we evaluated the expression levels of 
CD90, Sca-1, CD44 and CD29 (Figure 12E). Regarding the co-expression of Ki67 and CD90, a slight increase 
throughout ontogeny is observed. At E17 the percentage of proliferating CD90+ cells is approximately 40%, 
reaching 60% at P14. Statistically significant differences were found between E17 and P10 (p-value < 0,01), 
E17 and P14 (p-value < 0,05), P2 and P10 (p-value < 0,05). The expression of Sca-1 within the proliferative 
compartment also increases throughout ontogeny, starting at approximately 5% at E17 and reaching the 
maximum of approximately 80% in the adult. Statistically significant differences were found between E17 
and P14 (p-value < 0,05), E17 and adult (p-value < 0,01), P2 and adult (p-value < 0,01). These results are 
consistent with the augmentation of CD90+ and is particular, CD90+Sca-1+ throughout ontogeny. The 
proliferative compartment is mainly composed of cells with CD29 (integrin-β1) at their surface throughout 
ontogeny. However, a small, but statistical significant, reduction on the expression levels of this marker 
was observed post-birth. Once again, the biological relevance of such minor reduction is at present 
challenging to envisage. The percentage of CD44+ within the proliferative compartment increased 
throughout ontogeny. Statistically significant differences were found between P10 and P14 (p-value < 
0,001), P10 and adult (p-value < 0,01). 
We used the same approach to characterize the cardiac fibroblast population in apex-resected and sham 
operated animals at 7 days post-surgery (Figure 13A). Although the percentage of CD90+ cells was identical 
between groups, a significant decrease was observed in the frequency of CD140a+ (p-value < 0,01) and 
CD29+ (p-value < 0,05) cells together with an increase in the CD44+CD90+ and Sca-1+CD90+  cell 
compartments (p-value < 0,01 and 0,05, respectively). Once more, the percentage of CD140b- and Flk-1- 
expressing cells in the CD90+ compartment was negligible (Data not shown). Considering the proliferation 
in the stromal compartment (Figure 13B) no statistically significant differences were found on Ki67 
expression levels between injury and sham-operated animals. However, the percentage of Sca-1+ cells (p-
value < 0,001) within the proliferative compartment has almost doubled in injury conditions, when 
compared to sham-operated animals.  
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Figure 12 – A – Pheontypic characterization of cardiac fibroblasts (CD90+CD45 CD31-TER119-) throughout ontogeny. 
Hematopoietic (CD45+), endothelial (CD31+) and erythroid cells (TER119+) were excluded from the analysis. Within the 
stromal compartment i.e. CD45-CD31-TER119-, cardiac fibroblasts were identified by the expression of CD90 (B). The 
expression of mesenchymal-affiliated marker and adhesion molucules was further investigated in the CD90+ 
fibroblasts (C). E17 (n=6); P2 (n=11); P10 (n=11); P14 (n=11); Adult (n=4). The stromal proliferative compartment, 
trougout ontogeny, was ascribed by Ki67 expression profile (D) and finne characterized (E). E17 (n=4); P2 (n=7); P10 
(n=8); P14 (n=8); Adult (n=4). * (p-value < 0,05), ** (p-value < 0,01), *** (p-value < 0,001). 
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Figure 13 – A - Dynamics of Cardiac Fibroblast Populations 7 days after apex-resection. CD90 expression profile of the 
stromal compartment (CD31-CD45-TER119-) population was investigated post-apex resection (dpr) and post-sham 
surgery (dps) [white bars]. B – Dissection of proliferative populations of the heart stroma (CD31-CD45-TER119-) 
activated 7 dpr. * (p-value < 0,05), ** (p-value < 0,01), *** (p-value < 0,001). (n=5, 7 dpr); (n=6, 7 dps).  
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In 2008, cardiovascular diseases were responsible for approximately 17,3 million deaths, 
representing 30% of global mortality. Presently, heart conditions are ranked first in mortality 
causes worldwide and the available projections point for the prevalence of this tendency (72, 
73). As the only long term effective therapy for heart failure rely on cardiac transplantation, the 
scientific community has focused on the identification of cues that can promote cardiac 
regeneration or, to the least, lead to improved repair following injury. 
Heart regeneration was first observed in lower vertebrates such as zebra-fish and urodele 
amphibians. Despite the long phylogenetic distance between these organisms and mammals, in 
2011 Porrello et al. reported that murine hearts fully recovered from apex-resection within 21 
days, as long as it was performed during the first week of life. In contrast, after inflicting the 
same lesion in 7 days old mice, the heart appeared to engage on a reparative response that 
encompasses the formation of a collagen-rich scar, thus resulting in the deterioration of cardiac 
function (25). This ground-breaking work demonstrated the intrinsic regenerative potential of 
the mammalian heart, which holds great promise for the development of novel therapeutic 
approaches. In the following years others have replicated the neonatal regenerative response 
using different models of cardiac injury (26–29). However in 2014, Andersen et al. refuted the 
existence of cardiac regeneration in mice, by reporting a scar-based response in neonatal apex-
resected mice, questioning the usefulness of this model to study the molecular mechanisms 
underlying regeneration of the adult heart after damage. 
 
The herein work aims to determine the dynamics of the cardiac fibroblasts and of ECM in 
neonatal cardiac injury. Therefore, we established the neonatal apex-resection model at our 
laboratory (Figure 6). The mice strain and the neonatal day in our model are different from the 
original report, which may account for differential results/outcomes. Nevertheless, the surgery 
is performed in P2 neonates, which are still within the reported neonatal regenerative window. 
 
Regarding the histological characterization, the results show that, in our experimental setting, 
apex-resected hearts do not completely regenerate 2 months after surgery since collagen-rich 
extracellular matrix depositions are noticeable and spreading from the resected apex to the 
ventricular lumen (Figure 7). In this particular aspect, our results support the recent claim that 
neonates do not undergo complete regeneration. However, the scarring herein reported is not 
extended to the total apex but rather restricted to central sections, which is suggestive of an 
incomplete reestablishment of the apex. In this scenario, regenerative mechanisms would have 
to be activated to induce partial tissue growth being however insufficient for full histological 
restoration. Moreover, apex-resected animals displayed preserved systolic function, here 
assessed by ejection fraction and fraction shortening at 21 days post-surgery, when compared 
to sham-operated animals (Figure 8). Indeed, the only altered parameter was the LVIDd in the 
long-axis, which might relate with small left-ventricle dilation that did not produce a detectable 
impact on cardiac function. 
 
To further understand the cellular and extracellular compartments actively involved in the 
neonate response to injury, we co-localized markers of cardiomyocytes, smooth muscle 
cells/myofibroblasts, fibroblasts, hematopoietic and endothelial cells with several extracellular 
matrix proteins, namely: fibronectin, laminin, collagen IV and tenascin-C (Figure 9).  
Unsurprisingly, as consequence of apex-resection, a disruption on the expression pattern of s-
α-actinin, laminin and collagen IV was noticeable. However, at 21 dpr their expression patterns 
were partly restored, suggesting a partial recovery of the heart.  
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The neonatal apex response seems to encompass the formation of a fibronectin-rich blood clot, 
followed by the establishment of a strong inflammatory reaction that peaks around day 5, given 
the accumulation of CD45-expressing cells at the injury site. Nevertheless, a dramatic reduction 
in the abundance of CD45 is observed between 5 and 7 days post-surgery which appear to 
correlate with an increase in fibroblasts (vimentin) and myofibroblasts (α-SMA), abundant cell-
types at this time-point. At 21 dpr, the inflammatory process seems to be resolved (the number 
of CD45 expressing cells returned to sham-operated levels) and myofibroblasts have been 
removed from the injured area. Interestingly, fibronectin and tenascin-C expression overlaps 
with areas of hematopoietic cells (CD45+) and myofibroblasts (α-SMA+). These ECM proteins are 
significantly up-regulated from 48 hpr and remain overexpressed until 14 dpr (fibronectin) and 
21 dpr (tenascin-C). Our results suggest that the augmentation of fibronectin has a triple origin 
depending on the time post-surgery. Hence, during the first 48h fibronectin originates in the 
blood clot, since is an abundant soluble constituent of blood plasma (74). During the 
inflammatory phase (48 hour to 5 days post-resection), fibronectin seems to be produced by 
hematopoietic cells. On the other hand, following inflammation dimming, myofibroblasts 
produce de novo fibronectin, given the co-localization of both expression patterns. Tenascin-C 
and α-SMA co-detection was not possible because of technical limitations; however, owing to 
the similarity in the deposition of both proteins in the injured area, we speculate that 
myofibroblasts may also contribute to tenascin-C production and secretion. Fibronectin and 
tenascin-C deposition is also observed following cardiac injury in zebrafish (60, 61) and newt 
(62). Fibronectin mediates a wide variety of cellular interactions and has been suggested to 
mediate the opsonisation of tissue debris, migration, proliferation and contraction of cells 
involved in tissue regeneration as well as in angiogenesis (75). In zebrafish, injury-mediated 
fibronectin deposition is fundamental to promote cardiomyocyte migration to the injury site 
while not affecting specifically their proliferation (60). In newt, fibronectin is part of a 
regenerative ECM, alongside tenascin-C and hyaluronic acid, which promotes cardiomyocytes 
cell-cycle reentry (62). Hyaluronic acid is known to provide a hydrated environment and 
tenascin-C, in turn, is known to have counter-adhesive domains (61, 62). Altogether, the 
accumulation of these molecules in the damaged myocardium likely improves cell migration to 
the injury site. 
To investigate whether fibronectin and tenascin-C were promoting cell proliferation and/or 
migration of proliferative cardiomyocytes we verified that the deposition of these ECM 
components overlap at the injury site, followed by co-detection of fibronectin with proliferating 
cardiomyocytes (s-α-actinin+PH3+) (Figure 10). Higher mitotic levels were observed in areas of 
fibronectin deposition as well as in the adjacent myocardium. Proliferation in the injury site is 
mainly observed in hematopoietic cells (CD45+) and myofibroblasts (α-SMA+) (data not shown) 
whereas in the neighbouring myocardium proliferation is mostly observed in cardiomyocytes. 
Moreover, high-content imaging analysis showed that, at 7 days post-surgery, proliferation was 
augmented in that apex region, and in particular of cardiomyocytes, when compared to sham-
operated control group.  
Overall, our results demonstrate that the neonatal injury response at P2 involves the formation 
of a blood clot, recruitment of inflammatory cells, myofibroblasts proliferation and ECM 
remodelling that encompassed the production of fibronectin and tenascin-C. Although, these 
mechanisms are part of regenerative response observed in lower vertebrates, they are also a 
common feature of the reparative response observed in the adult mammalian heart (76–78) and 
therefore cannot argue in favour of the hypothesis of neonatal regeneration. Nonetheless, 
neomyogenesis is a particular feature of neonatal response to injury (25, 27, 79), and 
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differentiates neonatal heart compared to the adult mouse heart. Herein, evidence is provided 
for that, following apex-resection, P2 hearts activate mechanisms of cardiomyocyte 
proliferation which account for higher myocyte proliferation rates found in injured animals 
when compared to the sham-control. However, unlike initial claims of regeneration with 
negligible levels of fibrosis, our results demonstrate that fibrotic mechanisms are activated as 
such that a transmural scar is also formed in the central region of the apex. To wrap up, we find 
evidence for conserved regenerative mechanisms that seem to be activated following neonatal 
injury, although still at a level insufficient for full-reestablishment of the native tissue integrity. 
 
Fibroblasts are activated following neonatal injury and seem to contribute by at least 
differentiating into myofibroblasts which are main ECM producers. Aiming at dissecting the 
fibroblast population/s involved in this processes, and because neonatal fibroblast populations 
have not been well characterized, we initiated a study to phenotypically portray fibroblast 
population/s, selected on the basis of CD90 expression (CD31-CD45-TER119-CD90+), throughout 
ontogeny. The number of CD90 expressing cells in the stromal compartment significantly 
increased all through development, which is concordant with the presently recognized idea that 
the majority of fibroblast colonize the myocardium after birth (33, 80, 81) (Figure 12B). Within 
the cardiac fibroblast population we established the expression profile of CD29, Sca-1, CD44, 
CD140a, CD105 and CD106 (Figure 12C). The large majority of cardiac fibroblasts (>90%), 
independently of the ontogenic stage, display CD29 (β1-integrin) at their surface. Sca-1 has been 
commonly used to identify CPCs, however this protein is generally expressed in mesoderm-
derived cells and is not restricted to stem/progenitor cells. In fact, the cardiac Sca-1+ CPCs has 
been shown to be highly heterogeneous, displaying features commonly associated with 
fibroblasts (10). Not surprisingly, we detected a significant increase throughout ontogeny of the 
Sca-1+ CD90+ population, suggesting that approximately 70% of adult cardiac fibroblasts express 
Sca-1. Similarly to Sca-1, CD140a, CD105 and CD106 are widely expressed in cells of 
mesenchymal origin, such as fibroblasts. Each of these markers was significantly increased 
throughout development, which accounts for the fact that fibroblasts are considered a 
heterogeneous population. CD44 is known to be a hyaluronic acid receptor, although it can 
interact with other ligands (82). Additionally, CD44-dependent activation of TGF-β signalling was 
associated with fibroblast activation and posterior migration to injury sites (83). As anticipated, 
we did not observe significant changes in the expression of CD44 by cardiac fibroblasts 
throughout ontogeny since no injury stimulus was provided.  
Owing to a seemingly increase in fibroblasts throughout ontogeny we then hypothesized that 
these cells are the main contributors to the proliferation observed in the stromal population. To 
test this premise we analysed the dynamics of the stromal proliferative compartment (CD31-
CD45-TER119-Ki67+), which as described in the literature, is severely reduced with aging (5, 6) 
(Figure 12D). Within the proliferative compartment a phenotypic switch between the fetal and 
adult life could be detected. While at E17, the majority of proliferative cells are Sca-1- and CD90, 
in the adult life the majority of the proliferative compartment expresses these markers. 
Interestingly, all proliferating cells are expressing CD29 regardless of the ontogenic stage. 
Overall these results indicate that the majority of proliferating cells in the adult heart stromal 
compartment are CD90+ cardiac fibroblasts. Of importance, Sca-1+ cells comprise more than 70% 
of the proliferating cells, whether these cells are fibroblast or so called CPCs is yet to be analysed. 
 
To determine if specific populations of cardiac fibroblasts are activated upon neonatal heart 
injury we evaluated the expression levels of the aforementioned proteins in apex-resected and 
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sham-operated animals 7 days post-surgery. A statistical significant reduction on frequency of 
CD140a+ and CD29+ within the CD90+ population of cardiac fibroblasts was observed. Both 
switches involve minor changes, although, when considering that the injury only affects a small 
fraction of the heart, it is our perception that all differences should be considered and subjected 
to further analysis. Contrarily to CD140a+ and CD29+, Sca-1+ and CD44+ cardiac fibroblasts are 
more abundant in apex-resected animals. Indeed both Sca-1+ and CD44+ are reported to be 
activated in injury situations in the adult heart. While Sca-1+ cells activated upon MI have been 
associated to a progenitor-like phenotype (65, 84, 85), up-regulation of CD44 relates with 
activation of fibroblasts (83). Nonetheless, when the proliferation is analysed following apex-
resection, Sca-1+ cells are the only population that displays higher proliferative rates. Further 
studies are required to investigate the functional relevance of these populations either in normal 
heart physiology and following activation during neonatal injury response. 
 
  
9. Conclusion 
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Here we demonstrate that the neonatal heart injury response at P2 involves the formation of a 
blood clot, recruitment of inflammatory cells, myofibroblasts proliferation, ECM remodelling 
(production of fibronectin and tenascin-C) and activation of cardiomyocytes proliferation. Also, 
alike Andersen et al. we were not able to observe a complete restoration of the apex following 
cardiac injury, instead, cardiac fibrosis was observed although confined to the most central 
portion of the resected area. In fact, the model that best suits our data suggests that following 
apex resection, a blood clot is formed to prevent extensive haemorrhage. Then, ECM 
remodelling occurs, with the deposition of fibronectin and tenascin-C, firstly associated to 
hematopoietic cells and later to fibroblasts/myofibroblasts. This scenario likely promotes 
cardiomyocyte proliferation and migration towards the injured area, partially recovering the lost 
apex. In the innermost region of the apex, where the lumen was exposed, cardiomyocyte 
turnover is not sufficient to ensure complete repopulation and cardiac fibrosis arise (Figure 14) 
Still, further studies are needed to improve the statistical robustness of these results and to 
investigate the functional relevance of the observed ECM dynamics. 
The ontogenic phenotyping of the heart stroma showed that CD90+ fibroblasts colonize the 
heart following birth and that constitute the majority of proliferating cells throughout 
adulthood. CD90+ cardiac fibroblasts suffer a phenotypic switch with aging, which is clearly 
exemplified by increase on the percentage of Sca-1+ from residual levels at P2 to 70% in adult 
life. Interestingly, CD90+Sca-1+ cells seem to be activated following neonatal heart injury. The 
functional relevance of this observation is yet to be assessed. 
  
Figure 14 – Model proposed for the biological mechanisms underlying neonatal cardiac injury. After resection, a blood 
clot is formed and is gradually replaced by proliferating fibroblasts and myofibroblasts. Concomitantly, ECM 
remodelling occurs by accumulation of fibronectin and tenascin-C, initially associated with hematopoietic cells and 
afterwards with fibroblasts/myofibroblasts. While this environment assists cardiomyocyte migration and proliferation 
from the neighbouring myocardium to the apex, at the central region, where the lumen was exposed, cell repopulation 
is insufficient and cardiac fibrosis settles. 
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Supplementary Figure 1 – Low power images of Masson’s Trichrome and Hematoxilin-Eosin sections of apex-resected hearts at 0, 2, 5, 7, 14, 21 and 60 days post-apex resection surgery (perfomed at P2). These images 
emphasize the progression of the injury throughout the heart. Representative sampling of the heart was performed by using appropriate spacing between adjacent sections, which vary according to the ontogenic timepoint 
(see methods). 0, 2, 5, 7, 14 dpr (n=1); 21 dpr (n=4); 60 dpr (n=2). Scale bars: 1 mm (0, 2, 5, 7, 14, 21 dpr), 2 mm (60 dpr). 
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Supplementary Figure 2 – Flk-1 and CD140b expression profile of CD90 expressing cells troughout ontogeny. E17 (n=6); P2 (n=11); 
P10 (n=11); P14 (n=11); Adult (n=4). * (p-value < 0,05). 
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Supplementary Figure 3 – Co-localization of DAPI, s-α-Actinin, CD45 and PH3 in a representative section of the 7 dpr 
heart. Quantification of mitotic cells in the apex was performed considering the region between the papillary muscles 
and the apex (yellow highlight). Isolation of PH3 staining allows the detection of a proliferative gradient (more  
proliferation in the distal than in the proximal myocardium).Scale-bar, 1000μm. 
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Supplementary Figure 4 – Co-localization of DAPI, s-α-Actinin, CD45 and PH3 in a representative section of the 
7 dps heart. Quantification of mitotic cells in the apex was performed considering the region between the 
papillary muscles and the apex (yellow highlight). Comparing to 7 dpr, the isolation of PH3 staining does not 
have a proximo-distal gradient and the number of mitotic cells is decreased. Scale-bar, 1000μm. 
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